| Developers: | Moscow Institute of Physics and Technology (MIPT), First Moscow State Medical University named after I.M. Sechenov (First Moscow State Medical University) |
| Date of the premiere of the system: | August 2024 |
| Branches: | Pharmaceuticals, Medicine, Healthcare |
2024: Product Announcement
In Russia, at the end of August 2024, an innovative apparatus for blood testing was presented, which allows you to determine indicators without a finger puncture. The development, created by the joint efforts of specialists from Sechenov University and the Moscow Institute of Physics and Technology (MIPT), opens up new opportunities in the field of medical diagnostics.
According to TASS, the device is capable of measuring blood sugar levels in 30-60 seconds, as well as determining cholesterol and hemoglobin indicators. One of the key features of the device is the absence of the need to use reagents or test strips, which makes it convenient and cost-effective for everyday use. One of the authors of the development, Ekaterina Poliker, emphasized that the device is based on the Raman spectroscopy method and the use of machine learning technologies, which guarantees high measurement accuracy.
The uniqueness of the development lies in the fact that the device uses laser radiation for blood tests, and the results are processed using special software based on artificial intelligence.
The developers are confident that their technology will help significantly improve control over the condition of patients with diabetes and reduce the risk of complications. The device is undergoing pilot testing in several large Moscow laboratories. The developers plan to reduce the size of the device to a pocket format to make it as convenient as possible for use.
The development of this apparatus represents a significant breakthrough in the field of non-invasive diagnostic methods, which is especially important for patients with diabetes mellitus. According to WHO, more than 10 million Russians suffer from this disease. Today (August 2024), monitoring glucose and glycated hemoglobin requires blood sampling, which is associated with certain inconveniences and additional costs for materials. The new device allows you to analyze quickly and painlessly.[1]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |